As the battle rages on over the plant to obtain anti-Covid vaccines, the African Union claims to have secured 400 million additional doses, bringing the number of pre-purchased doses to 670 million. The continent hopes to receive these vaccines as early as April.
The 400 million newly acquired doses will be provided by India, and in particular by the Serum Institute of India, which manufactures the vaccine developed by the British laboratory AstraZeneca. 50 million doses could reach the continent by the beginning of April, says John Nkengasong, director of CDC, the African center for disease control. He is optimistic that his body has already secured a total of 670 million doses of vaccine. According to specialists, a total of 1.5 billion doses would be needed to vaccinate 60% of the populations of Africa.